SCHEMBL33258

SCHEMBL33258

CCCn1ccnn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29291876 0.93 CYP19A1 (0.38)
SCHEMBL30428067 0.84 CYP19A1 (0.39)
Tetrahydrofuran SCHEMBL28280318 0.84 CYP19A1 (0.33)
Nitric Acid SCHEMBL1351895 0.84 CYP19A1 (0.33)
SCHEMBL628307 0.84 TBXAS1 (0.42)
SCHEMBL11361006 0.84 CYP19A1 (0.48)
SCHEMBL15212439 0.83 CYP19A1 (0.38)
SCHEMBL11204798 0.82 TBXAS1 (0.46)
SCHEMBL20204363 0.82 TBXAS1 (0.46)
SCHEMBL21925549 0.82 TBXAS1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4655285-A1 CALIX[4]ARENES WITH HIGH ANTICANCER ACTIVITY Université Grenoble Alpes (FR) 2025-12-03 EP claimed
WO-2024156819-A1 CALIX[4]ARENES WITH HIGH ANTICANCER ACTIVITY UNIVERSITE GRENOBLE ALPES (FR) 2024-08-02 WO claimed
US-20260015339-A1 CALIX[4]ARENES WITH HIGH ANTICANCER ACTIVITY UNIVERSITE GRENOBLE ALPES (FR) 2026-01-15 US disclosed
EP-4655285-A1 CALIX[4]ARENES WITH HIGH ANTICANCER ACTIVITY Université Grenoble Alpes (FR) 2025-12-03 EP disclosed
US-12304973-B2 Polysaccharide derivative production method and lignin derivative production method NATIONAL UNIVERSITY CORPORATION KANAZAWA UNIVERSITY (JP) 2025-05-20 US disclosed
WO-2024156819-A1 CALIX[4]ARENES WITH HIGH ANTICANCER ACTIVITY UNIVERSITE GRENOBLE ALPES (FR) 2024-08-02 WO disclosed
EP-4406939-A1 CALIX[4]ARENES WITH HIGH ANTICANCER ACTIVITY Université Grenoble Alpes (FR) 2024-07-31 EP disclosed
US-20240231230-A1 COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM NISSAN CHEMICAL CORPORATION (JP) 2024-07-11 US disclosed
US-20240218011-A1 GLUCOCORTICOID RECEPTOR AGONISTS AND CONJUGATES THEREOF FIREFLY BIO, INC. 2024-07-04 US disclosed
WO-2024119117-A1 MODIFIED 5' CAP FOR MRNA AND METHODS OF USE THEREOF PRIME MEDICINE, INC. (US) 2024-06-06 WO disclosed
US-20240118612-A1 PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR MANUFACTURING RESIST PATTERN FILM, AND METHOD FOR MANUFACTURING PLATED SHAPED ARTICLE JSR CORPORATION (JP) 2024-04-11 US disclosed
US-4727159-A FUNGICIDES PFIZER INC. (US) 1988-02-23 US disclosed
CN-86102389-A The preparation and the application thereof of the aralkyl compound that the azoles base replaces 1987-01-21 CN disclosed
US-4638007-A 1-(3-SUBSTITUTED)-2-HYDROXY-2-PERFLUORO ALKYL PROPYL TRIAZOLE PFIZER INC. (US) 1987-01-20 US disclosed
EP-0087534-A1 4-Anilinophenoxy alkoxysilanes and their use as antioxidants OLIN CORPORATION (US) 1983-09-07 EP disclosed
US-4381306-A Hydroxypropyl-triazole compounds, their production and their medicinal use BAYER AKTIENGESELLSCHAFT (DE) 1983-04-26 US disclosed
US-4375420-A Selected 4-hydroxyphenyl anilino alkoxysilanes and their use as antioxidants OLIN CORPORATION (US) 1983-03-01 US disclosed
US-4234441-A Silicone oil compositions containing silicate cluster compounds OLIN CORPORATION (US) 1980-11-18 US disclosed
US-4079142-A 1-Propyl-triazolyl antimycotic compositions and methods of treating mycoses BAYER AKTIENGESELLSCHAFT (DT) 1978-03-14 US disclosed
US-3993765-A ANTIMUCOTICS BAYER AKTIENGESELLSCHAFT (DT) 1976-11-23 US disclosed